As Cannabis Users Age, Health Risks Appear To Grow
More older people are using cannabis products regularly, but research suggests their cannabis-related health problems are also on the rise.
Affordable Care Act
61 - 80 of 3,600 Results
-
Trump’s ‘One Big Beautiful Bill’ Lands in Senate. Our 400th Episode!
Episode 400The House’s gigantic tax-and-spending budget reconciliation bill has landed with a thud in the Senate, where lawmakers are divided in their criticism over whether it increases the deficit too much or cuts Medicaid and the Affordable Care Act too deeply. Meanwhile, the Congressional Budget Office’s estimate that the bill, if enacted, could increase the ranks of the uninsured by nearly 11 million people over a decade won’t make it an easy sell. Alice Miranda Ollstein of Politico, Jessie Hellmann of CQ Roll Call, and Lauren Weber of The Washington Post join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Arielle Zionts, who reported and wrote the latest “Bill of the Month” feature, about a Medicaid patient who had an out-of-state emergency.
-
Trump’s ‘One Big Beautiful Bill’ Continues Assault on Obamacare
The domestic policy legislation the House advanced in May includes the most substantial rollback of the Affordable Care Act since President Donald Trump and his Republican allies tried to pass legislation in 2017 that would have largely repealed President Barack Obama’s signature domestic accomplishment.
By Phil Galewitz and Julie Appleby Bill With Billions in Health Program Cuts Passes House
Episode 398The House narrowly passed a budget reconciliation bill, including billions of dollars in tax cuts for the wealthy along with billions of dollars in cuts to health program spending. But the Senate is expected to make major changes to the measure before it can go to President Donald Trump for his signature. This week’s panelists are Julie Rovner of KFF Health News, Anna Edney of Bloomberg News, Sarah Karlin-Smith of the Pink Sheet, and Alice Miranda Ollstein of Politico.
GOP Tries To Cut Billions in Health Benefits
Episode 397GOP-controlled House committees approved parts of President Donald Trump’s “one big, beautiful bill” this week, including more than $700 billion in cuts to health programs over the next decade — mostly from Medicaid, which covers people with low incomes or disabilities. Meanwhile, Health and Human Services Secretary Robert F. Kennedy Jr. testified before Congress for the first time since taking office and told lawmakers that Americans shouldn’t take medical advice from him. Julie Appleby of KFF Health News, Alice Miranda Ollstein of Politico, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News’ Julie Rovner to discuss these stories and more.
Cutting Medicaid Is Hard — Even for the GOP
Episode 396Republicans on Capitol Hill are struggling to reach consensus on cutting the Medicaid program as they search for nearly a trillion dollars in savings over the next decade — as many observers predicted. Meanwhile, turmoil continues at the Department of Health and Human Services, with more controversial cuts and personnel moves, including the sudden nomination of Casey Means, an ally of Robert F. Kennedy Jr.’s, to become surgeon general. Anna Edney of Bloomberg News, Maya Goldman of Axios, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Lauren Sausser, who co-reported the latest “Bill of the Month” feature, about an unexpected bill for what seemed like preventive care.
-
The Ranks of Obamacare ‘Fixers’ Axed in Trump’s Reduction of Health Agency Workforce
These fixers, officially known as caseworkers, unraveled complex and arcane health insurance rules to solve people’s coverage issues. They worked in a little-known federal department with which most consumers never interact — until they need help.
-
What To Know About Trump’s Executive Orders on US Health Care
From rolling back drug pricing policies to limiting gender-affirming care, President Donald Trump signed several health-related executive orders in the first hours of his second presidency. Here’s a roundup of the changes and what they mean.
-
Federal Judge Halts Dreamers’ Brand-New Access to ACA Enrollment in 19 States
A federal judge sided with 19 states seeking an injunction against a Biden administration rule allowing recipients of Deferred Action for Childhood Arrivals to enroll in Affordable Care Act coverage and qualify for subsidies amid the annual open enrollment period.
-
Trump Doesn’t Need Congress To Make Abortion Effectively Unavailable
President-elect Donald Trump vowed on the campaign trail not to sign a nationwide abortion ban. But he wouldn’t need to do so to make abortion difficult, or illegal, writes KFF Health News’ chief Washington correspondent, Julie Rovner.
By Julie Rovner Trump’s Nontraditional Health Picks
Episode 373Not only has President-elect Donald Trump chosen prominent vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services, Trump also has said he will nominate controversial TV host Mehmet Oz to run the Centers for Medicare & Medicaid Services, which oversees coverage for nearly half of Americans. Meanwhile, the lame-duck Congress is back in Washington with just a few weeks to figure out how to wrap up work for the year. Rachel Cohrs Zhang of Stat, Sandhya Raman of CQ Roll Call, and Riley Ray Griffin of Bloomberg News join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Sarah Varney, who has been covering a trial in Idaho challenging the lack of medical exceptions in that state’s abortion ban.
Readying for Republican Rule
Episode 372With Republicans now set to control the White House, Senate, and House of Representatives starting in January, their health agenda remains unclear. What is clear, however, is that just about anything could be on the table, from Medicare, Medicaid, and the Affordable Care Act, to drug prices and public health. Meanwhile, anti-abortion groups are preparing to fight the implementation of abortion rights ballot measures just passed by voters in seven states. Rachel Roubein of The Washington Post, Anna Edney of Bloomberg News, and Lauren Weber of The Washington Post join KFF Health News’ Julie Rovner to discuss these stories and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.
Trump 2.0
Episode 371As Donald Trump readies for his return to the White House — with the backing of a GOP majority in the Senate and, possibly, the House — the entire health care industry is waiting to see what happens next. Clearly on the agenda: the future of abortion and reproductive rights, Medicare, Medicaid, the Affordable Care Act, and public health’s infrastructure. Rachel Cohrs Zhang of Stat and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Jackie Fortiér, who reported and wrote the latest KFF Health News-Washington Post “Bill of the Month” feature, about a 2-year-old who had a very expensive run-in with a rattlesnake.
-
What’s at Stake: A Pivotal Election for Six Big Health Issues
Health care has ebbed and surged as an election issue throughout the presidential campaign. Here are the ways some of the most consequential changes in health policies could hinge on whether Vice President Kamala Harris or former President Donald Trump wins.
The Campaign’s Final Days
Episode 370It’s the final days of the 2024 campaign, and Republicans are suddenly talking again about making changes to the Affordable Care Act if former President Donald Trump wins. Meanwhile, new reporting uncovers more maternal deaths under state abortion bans — and a case in which a Nevada woman was jailed after a miscarriage. Lauren Weber of The Washington Post, Shefali Luthra of The 19th, and Jessie Hellmann of CQ Roll Call join KFF Health News’ Emmarie Huetteman to discuss these stories and more. Also this week, KFF Health News’ Julie Rovner interviews Irving Washington, a senior vice president at KFF and the executive director of its Health Misinformation and Trust Initiative.
-
In Montana, Conservative Groups See Chance To Kill Medicaid Expansion
Conservative groups are working to undermine support for Montana’s Medicaid expansion ahead of a political fight over whether to keep the program.
-
‘Dreamers’ Can Enroll in ACA Plans This Year — But a Court Challenge Could Get in the Way
Nineteen states are seeking to stall a Biden administration rule that would allow recipients of the Deferred Action for Childhood Arrivals program to enroll in ACA coverage and qualify for subsidies. DACA provides work authorization and temporary deportation protection to people brought to the U.S. as children without immigration paperwork.
-
Presidential Election Puts Affordable Care Act Back in the Bull’s-Eye
The outcome of the upcoming presidential election could affect the number of insured Americans, the fate of premium-reducing subsidies, the shape of Medicaid, and the cost of coverage for tens of millions of people.
LIVE From KFF: Health Care and the 2024 Election
Episode 368The Affordable Care Act has not been a major issue in the 2024 campaign, but abortion and reproductive rights have been front and center. Those are just two of the dozens of health issues that could be profoundly affected by who is elected president and which party controls Congress in 2025. In this special live episode, Tamara Keith of NPR, Alice Miranda Ollstein of Politico, and Cynthia Cox and Ashley Kirzinger of KFF join KFF Health News chief Washington correspondent Julie Rovner to discuss how health policy has affected the campaign and how the election results might affect health policy. Plus, the panel answers questions from the live audience.
-
FDA’s Promised Guidance on Pulse Oximeters Unlikely To End Decades of Racial Bias
For decades, the pulse oximeters used in hospitals, ambulances, and homes have underestimated the oxygen needs of darker-skinned patients. The FDA is preparing guidelines to fix that. But will the new rules go far enough?
By Arthur Allen